Transcat, Inc. (NASDAQ:TRNS) Shares Acquired by Northern Trust Corp

Northern Trust Corp grew its position in Transcat, Inc. (NASDAQ:TRNS) by 6.7% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 114,755 shares of the scientific and technical instruments company’s stock after acquiring an additional 7,171 shares during the period. Northern Trust Corp owned about 1.23% of Transcat worth $12,134,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of the company. Neuberger Berman Group LLC raised its position in shares of Transcat by 1.8% in the fourth quarter. Neuberger Berman Group LLC now owns 873,985 shares of the scientific and technical instruments company’s stock worth $92,415,000 after acquiring an additional 15,723 shares during the period. Champlain Investment Partners LLC grew its stake in Transcat by 35.7% during the 4th quarter. Champlain Investment Partners LLC now owns 555,650 shares of the scientific and technical instruments company’s stock valued at $58,754,000 after acquiring an additional 146,150 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its stake in Transcat by 178.0% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 518,597 shares of the scientific and technical instruments company’s stock valued at $54,837,000 after acquiring an additional 332,064 shares in the last quarter. Geode Capital Management LLC grew its stake in Transcat by 0.9% during the 4th quarter. Geode Capital Management LLC now owns 219,354 shares of the scientific and technical instruments company’s stock valued at $23,200,000 after acquiring an additional 1,881 shares in the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in Transcat by 5.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 209,200 shares of the scientific and technical instruments company’s stock valued at $22,121,000 after acquiring an additional 10,186 shares in the last quarter. Institutional investors and hedge funds own 98.34% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on TRNS. HC Wainwright dropped their price objective on shares of Transcat from $126.00 to $106.00 and set a “buy” rating for the company in a research note on Wednesday, January 29th. Northland Securities reissued a “market perform” rating and issued a $85.00 price target (down previously from $110.00) on shares of Transcat in a research note on Wednesday, January 29th. Oppenheimer cut shares of Transcat from an “outperform” rating to a “market perform” rating in a research note on Wednesday, January 29th. Finally, StockNews.com cut shares of Transcat from a “hold” rating to a “sell” rating in a research note on Wednesday, February 5th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $111.50.

Transcat Stock Performance

Shares of TRNS stock opened at $81.25 on Friday. The firm has a market cap of $756.36 million, a P/E ratio of 43.92 and a beta of 0.69. Transcat, Inc. has a one year low of $67.56 and a one year high of $147.12. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.98 and a current ratio of 2.42. The firm’s 50 day moving average price is $77.67 and its 200-day moving average price is $90.01.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.